Despite these limitations, we have provided novel evidence to support that the biologic parameter of glucose uptake magnitude correlates with RS; in turn, these findings support the prognostic value of the SUV for ER-positive, HER2-negative breast cancer. This evidence concerns the gene ERBB2 and breast cancer.